Search results
Results From The WOW.Com Content Network
AstraZeneca (AZN.L) will keep its freeze on manufacturing investments in Britain if the country's exit from the European Union fails to give enough clarity on future trading relations, the ...
Its main offices were located in Gaithersburg, MD, Cambridge, UK, and Mountain View, CA. [ 4 ] It produced Synagis , a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist , a nasal spray influenza vaccine introduced in 2004.
The AstraZeneca R&D facility in Mölndal near Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, United Kingdom. AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and ...
British finance minister Rachel Reeves wants to reduce state provisions to the company's vaccine centre, which will cut the pledge made by the previous administration from about 90 million pounds ...
Note: the activities of the parent companies of many of the companies listed below are not restricted solely to the United Kingdom. For example, AstraZeneca and GlaxoSmithKline, although headquartered in the United Kingdom, have activities in numerous other countries, and Johnson & Johnson and Pfizer are both headquartered in the United States ...
(Reuters) -Britain's competition regulator is reviewing AstraZeneca's planned $39 billion takeover of U.S.-based Alexion on whether it could reduce competition in Britain or other markets. The UK ...
The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. [8] It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, [9] Hoffmann–La Roche ...
For premium support please call: 800-290-4726 more ways to reach us